基本信息
浏览量:1
职业迁徙
个人简介
In addition to attending on the hospital’s Nephrology consult and ward services, he provides longitudinal care for patients on chronic hemodialysis and has an active general nephrology practice.
Dr. Wald’s research interests are in the areas of critical care nephrology and chronic dialysis. He is currently leading a Canadian Institutes of Health Research-funded international trial on the impact of the timing of dialysis initiation on survival in critically ill patients with acute kidney injury. He also has a strong interest in the long-term outcomes of patients who survive an episode of acute kidney injury and is co-leading a trial that is comparing specialized nephrology care vs usual care in this population. In the chronic dialysis area, Dr. Wald co-led a CIHR-funded study on the cardiovascular benefits of incentre nocturnal hemodialysis. He recently completed a multicentre pilot trial examining the implementation of two different levels of serum phosphate control in the hemodialysis population. A larger definitive trial to evaluate whether intensive serum phosphate lowering mediates improved clinical outcomes is planned. As a founding member of the Kidney Dialysis and Transplantation Program of the Institute for Clinical Evaluative Sciences, Dr. Wald is also involved in several studies that are using province-wide administrative data to answer research questions in kidney disease.
Dr. Wald’s research interests are in the areas of critical care nephrology and chronic dialysis. He is currently leading a Canadian Institutes of Health Research-funded international trial on the impact of the timing of dialysis initiation on survival in critically ill patients with acute kidney injury. He also has a strong interest in the long-term outcomes of patients who survive an episode of acute kidney injury and is co-leading a trial that is comparing specialized nephrology care vs usual care in this population. In the chronic dialysis area, Dr. Wald co-led a CIHR-funded study on the cardiovascular benefits of incentre nocturnal hemodialysis. He recently completed a multicentre pilot trial examining the implementation of two different levels of serum phosphate control in the hemodialysis population. A larger definitive trial to evaluate whether intensive serum phosphate lowering mediates improved clinical outcomes is planned. As a founding member of the Kidney Dialysis and Transplantation Program of the Institute for Clinical Evaluative Sciences, Dr. Wald is also involved in several studies that are using province-wide administrative data to answer research questions in kidney disease.
研究兴趣
论文共 290 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Keren Cohen-Hagai,Shira Goldman,Ron Wald, Victor Frajewicki, Gil Chernin, Nomy Levin Iaina,Pazit Beckerman, Alon Antebi,Yosef S Haviv, Sydney Benchetrit,Benaya Rozen-Zvi
Kidney360 (2024)
Mats L Junek,Peter A Merkel,Eswari Vilayur,Ron Wald,Nader Khalidi, David Jayne,Michael Walsh, PEXIVAS Investigators
Arthritis & rheumatology (Hoboken, N.J.) (2024)
Journal of Critical Care (2024): 154767-154767
Critical care explorationsno. 2 (2024): e1053-e1053
JOURNAL OF RHEUMATOLOGYno. 7 (2023): 21-21
引用0浏览0引用
0
0
PEDIATRIC NEPHROLOGYno. 7 (2023): 2256-2256
引用0浏览0引用
0
0
Cameron Giles, Milica Novakovic,Wilma Hopman,Erin F Barreto,William Beaubien-Souligny,Peter Birks,Javier A Neyra,Ron Wald,Samuel A Silver
Canadian journal of kidney health and disease (2023): 20543581231199018
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn